Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth ...
PEMGARDA (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 millionPreliminary Q4 2024 total operating costs and expenses of approximately ...